Development of novel thrombolytic agents.
Collen
D
D
Centre for Molecular and Vascular Biology, University of Leuven, Belgium.
De Bono
D P
DP
Lijnen
H R
HR
Pannekoek
H
H
D000818:Animals; D016255:Anistreplase / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D008666:Metalloendopeptidases; D010960:Plasminogen Activators / Q000494:pharmacology; D013300:Streptokinase / Q000494:pharmacology; D010959:Tissue Plasminogen Activator / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D016255:Anistreplase; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator; D008666:Metalloendopeptidases; C022653:auR protein, Staphylococcus aureus